Karina Madej-Świątkowska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Karina Madej-Świątkowska has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
D. Drozdz
Department of Pediatric Nephrology and Hypertension, Jagiellonian University Medical College
1 shared publication- Dorota Drożdż
Department of Pediatric Nephrology and Hypertension, Jagiellonian University Medical College, Krakow, Poland
1 shared publication - Ewelina Jarosz-Wójcik
Department of Pediatric Nephrology and Hypertension, Jagiellonian University Medical College, Cracow, Poland
1 shared publication - Katarzyna Zachwieja
Department of Pediatric Nephrology and Hypertension, Jagiellonian University Medical College, Krakow, Poland
1 shared publication - Magdalena Błasiak
Department of Pediatric Nephrology and Hypertension, University Children's Hospital, Cracow, Poland
1 shared publication - Monika Miklaszewska
Department of Pediatric Nephrology and Hypertension, Jagiellonian University Medical College, Cracow, Poland
1 shared publication
Latest Publications
- Open Access
- 22 July 2026
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 14, 1862008
Biochemical markers of endothelial injury in children with obesity—from adhesion molecules to novel endothelium-specific biomarkers
Introduction: Childhood obesity is no longer only a metabolic condition but an early vascular disease. Subclinical endothelial dysfunction develops long before overt cardiovascular complications and may contribute to the later emergence of atherosclerosis and hypertension. Detecting these early alterations remains a major challenge in pediatric care. Methods: This mini review integrates current evidence on circulating biochemical markers of endothelial injury in children with obesity, focusing on markers reflecting endothelial activation, hemostatic imbalance, and vascular dysfunction. Results: Multiple biomarkers are altered in pediatric obesity. Soluble adhesion molecules reflect early endothelial activation and low-grade inflammation. Hemostatic markers indicate a shift toward a prothrombotic state. Dysregulation of the NO–eNOS–ADMA axis contributes to reduced nitric oxide bioavailability and impaired vascular function. Emerging endothelium-specific biomarkers, including endocan and syndecan-1, offer greater specificity and appear to capture early vascular injury more sensitively than traditional inflammatory markers. Indirect markers further link metabolic, inflammatory, and oxidative pathways. Conclusions: Endothelial dysfunction represents an early, clinically silent but potentially reversible stage of obesity-related vascular disease in children. A multimarker approach may improve early risk identification and better reflect the complexity of underlying mechanisms. These findings support a shift toward earlier, multidisciplinary cardiovascular risk assessment in pediatric obesity and highlight the need for prospective studies to translate biomarkers into clinical practice.
- 22 July 2026
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 14, 1862008
Open AccessBiochemical markers of endothelial injury in children with obesity—from adhesion molecules to novel endothelium-specific biomarkers
Introduction: Childhood obesity is no longer only a metabolic condition but an early vascular disease. Subclinical endothelial dysfunction develops long before overt cardiovascular complications and may contribute to the later emergence of atherosclerosis and hypertension. Detecting these early alterations remains a major challenge in pediatric care. Methods: This mini review integrates current evidence on circulating biochemical markers of endothelial injury in children with obesity, focusing on markers reflecting endothelial activation, hemostatic imbalance, and vascular dysfunction. Results: Multiple biomarkers are altered in pediatric obesity. Soluble adhesion molecules reflect early endothelial activation and low-grade inflammation. Hemostatic markers indicate a shift toward a prothrombotic state. Dysregulation of the NO–eNOS–ADMA axis contributes to reduced nitric oxide bioavailability and impaired vascular function. Emerging endothelium-specific biomarkers, including endocan and syndecan-1, offer greater specificity and appear to capture early vascular injury more sensitively than traditional inflammatory markers. Indirect markers further link metabolic, inflammatory, and oxidative pathways. Conclusions: Endothelial dysfunction represents an early, clinically silent but potentially reversible stage of obesity-related vascular disease in children. A multimarker approach may improve early risk identification and better reflect the complexity of underlying mechanisms. These findings support a shift toward earlier, multidisciplinary cardiovascular risk assessment in pediatric obesity and highlight the need for prospective studies to translate biomarkers into clinical practice.
- 23 August 2025
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
Key technical aspects and vascular access safety in membrane-based therapeutic plasma exchange for the pediatric population
Introduction: Therapeutic plasma exchange (TPE) is a widely used extracorporeal blood purification procedure. While its principles are similar across age groups, the technical complexity and risks are heightened in pediatric patients due to unique technical considerations. This study assesses the safety regarding both technical and clinical complications of vascular access and filters of membrane technique TPE performed in a pediatric population at a single center.Material and methods: This retrospective cohort study reviewed charts of patients undergoing TPE at a level 3 referral center over 25 years.Results: The study involved 178 patients undergoing a total of 740 procedures during 214 sessions, predominantly using femoral vascular access. The median duration of the entire TPE sessions (treated as a surrogate for catheter lifespan) was 118.5 hours. Technical complications occurred in 20.8% of procedures (31.6% of events), while clinical complications occurred in 4.2% (4.7% of events). Technical complications were nearly five times more frequent than clinical complications, with technical events being 6.7 times more common. The proportion of patients experiencing clinical complications amounted to 15.2%. Logistic regression demonstrated that each additional day of catheter placement increased the probability of technical complications by 3%. Additionally, each year of patient age decreased the likelihood of clinical complications by 8.9%, while Fresh Frozen Plasma (FFP) supplementation within a session increased the probability of clinical complications by 21.6%.Conclusions: Prolonged catheter use increases technical events, while FFP supplementation elevates catheter-related clinical complication risk. Advancing patient age reduces the likelihood of clinical complications, underscoring age-specific safety considerations in pediatric TPE.
- 23 August 2025
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
Key technical aspects and vascular access safety in membrane-based therapeutic plasma exchange for the pediatric population
Introduction: Therapeutic plasma exchange (TPE) is a widely used extracorporeal blood purification procedure. While its principles are similar across age groups, the technical complexity and risks are heightened in pediatric patients due to unique technical considerations. This study assesses the safety regarding both technical and clinical complications of vascular access and filters of membrane technique TPE performed in a pediatric population at a single center.Material and methods: This retrospective cohort study reviewed charts of patients undergoing TPE at a level 3 referral center over 25 years.Results: The study involved 178 patients undergoing a total of 740 procedures during 214 sessions, predominantly using femoral vascular access. The median duration of the entire TPE sessions (treated as a surrogate for catheter lifespan) was 118.5 hours. Technical complications occurred in 20.8% of procedures (31.6% of events), while clinical complications occurred in 4.2% (4.7% of events). Technical complications were nearly five times more frequent than clinical complications, with technical events being 6.7 times more common. The proportion of patients experiencing clinical complications amounted to 15.2%. Logistic regression demonstrated that each additional day of catheter placement increased the probability of technical complications by 3%. Additionally, each year of patient age decreased the likelihood of clinical complications by 8.9%, while Fresh Frozen Plasma (FFP) supplementation within a session increased the probability of clinical complications by 21.6%.Conclusions: Prolonged catheter use increases technical events, while FFP supplementation elevates catheter-related clinical complication risk. Advancing patient age reduces the likelihood of clinical complications, underscoring age-specific safety considerations in pediatric TPE.